Barrow, Hanley, Mewhinney & Strauss’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$952M Buy
7,917,866
+124,690
+2% +$14.4M 3.12% 1
2025
Q4
$820M Buy
7,793,176
+377,906
+5% +$35.5M 2.73% 2
2025
Q3
$622M Sell
7,415,270
-1,291,412
-15% -$106M 1.98% 11
2025
Q2
$689M Buy
8,706,682
+915,584
+12% +$72.8M 2.32% 5
2025
Q1
$699M Buy
7,791,098
+1,505,193
+24% +$141M 2.54% 2
2024
Q4
$625M Buy
6,285,905
+629,303
+11% +$64.9M 2.13% 9
2024
Q3
$642M Sell
5,656,602
-235,154
-4% -$27.9M 2.1% 9
2024
Q2
$729M Sell
5,891,756
-290,704
-5% -$37.4M 2.49% 6
2024
Q1
$816M Sell
6,182,460
-357,187
-5% -$44M 2.75% 2
2023
Q4
$713M Sell
6,539,647
-1,401
-0% -$145K 2.51% 5
2023
Q3
$673M Sell
6,541,048
-73,762
-1% -$7.95M 2.57% 4
2023
Q2
$763M Sell
6,614,810
-1,577,768
-19% -$179M 2.84% 3
2023
Q1
$872M Sell
8,192,578
-1,254,396
-13% -$135M 3.37% 1
2022
Q4
$1.05B Sell
9,446,974
-690,099
-7% -$70.5M 3.94% 1
2022
Q3
$873M Sell
10,137,073
-792,510
-7% -$70.7M 3.58% 1
2022
Q2
$996M Sell
10,929,583
-133,528
-1% -$11.8M 3.76% 1
2022
Q1
$908M Buy
11,063,111
+590,396
+6% +$46.5M 2.96% 2
2021
Q4
$803M Buy
10,472,715
+261,025
+3% +$20.8M 2.54% 3
2021
Q3
$767M Buy
10,211,690
+66,038
+0.7% +$5.02M 2.54% 4
2021
Q2
$789M Buy
10,145,652
+9,399,131
+1,259% +$699M 2.53% 3
2021
Q1
$54.9M Buy
746,521
+704,581
+1,680% +$52M 0.17% 118
2020
Q4
$3.27M Sell
41,940
-539
-1% -$41.2K 0.01% 152
2020
Q3
$3.36M Sell
42,479
-26,138
-38% -$2.05M 0.01% 145
2020
Q2
$5.06M Hold
68,617
0.02% 138
2020
Q1
$5.04M Hold
68,617
0.02% 126
2019
Q4
$5.96M Sell
68,617
-603,148
-90% -$49.5M 0.02% 132
2019
Q3
$54M Sell
671,765
-1,108,222
-62% -$88.8M 0.11% 110
2019
Q2
$142M Sell
1,779,987
-164,256
-8% -$12.6M 0.26% 85
2019
Q1
$154M Sell
1,944,243
-1,429,313
-42% -$107M 0.28% 77
2018
Q4
$246M Sell
3,373,556
-2,566,462
-43% -$181M 0.48% 53
2018
Q3
$402M Sell
5,940,018
-822,688
-12% -$52.4M 0.64% 43
2018
Q2
$392M Sell
6,762,706
-6,628,614
-49% -$374M 0.63% 46
2018
Q1
$696M Sell
13,391,320
-1,497,646
-10% -$80.9M 1.11% 35
2017
Q4
$799M Sell
14,888,966
-959,626
-6% -$53.2M 1.19% 33
2017
Q3
$968M Sell
15,848,592
-439,968
-3% -$26.7M 1.46% 31
2017
Q2
$996M Sell
16,288,560
-285,849
-2% -$17.4M 1.51% 27
2017
Q1
$1B Sell
16,574,409
-1,941,765
-10% -$118M 1.51% 27
2016
Q4
$1.04B Sell
18,516,174
-956,748
-5% -$56M 1.56% 28
2016
Q3
$1.16B Sell
19,472,922
-8,315,919
-30% -$486M 1.77% 25
2016
Q2
$1.53B Sell
27,788,841
-154,519
-0.6% -$8.22M 2.33% 10
2016
Q1
$1.41B Buy
27,943,360
+8,736
+0% +$428K 2.16% 15
2015
Q4
$1.41B Buy
27,934,624
+1,546,952
+6% +$78M 2.1% 11
2015
Q3
$1.24B Sell
26,387,672
-484,224
-2% -$25.7M 1.91% 18
2015
Q2
$1.46B Buy
26,871,896
+1,233,502
+5% +$69.2M 1.99% 17
2015
Q1
$1.41B Buy
25,638,394
+1,684,327
+7% +$95.4M 1.91% 16
2014
Q4
$1.3B Buy
23,954,067
+92,063
+0.4% +$5.13M 1.74% 24
2014
Q3
$1.35B Sell
23,862,004
-25,277
-0.1% -$1.42M 1.84% 21
2014
Q2
$1.32B Buy
23,887,281
+56,778
+0.2% +$3.1M 1.77% 20
2014
Q1
$1.29B Sell
23,830,503
-7,005,651
-23% -$363M 1.85% 21
2013
Q4
$1.47B Sell
30,836,154
-228,235
-0.7% -$10.4M 2.13% 16
2013
Q3
$1.41B Buy
31,064,389
+338,335
+1% +$15.4M 2.26% 15
2013
Q2
$1.36B Buy
+30,726,054
New +$1.37B 2.29% 15

Other funds holding MRK

Barrow, Hanley, Mewhinney & Strauss's MRK Position: Q1 2026 in Review

Barrow, Hanley, Mewhinney & Strauss increased its Merck (MRK) stake by 1.6% in Q1 2026, buying an estimated $14.4M and bringing the position to 7,917,866 shares worth $952M. The position accounts for 3.12% of the portfolio, ranked #1.

Barrow, Hanley, Mewhinney & Strauss first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.53B in Q2 2016. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Barrow, Hanley, Mewhinney & Strauss held 7,917,866 shares of Merck worth $952M as of Q1 2026.
  • Barrow, Hanley, Mewhinney & Strauss bought 124,690 Merck shares in Q1 2026, an estimated $14.4M.
  • Merck made up 3.12% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q1 2026, its #1 holding.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Barrow, Hanley, Mewhinney & Strauss's Merck position peaked at $1.53B in Q2 2016.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q1 2026, filed 13 May 2026.